Related Experiment Video
Updated: Jun 8, 2026

A Non-Coding Small RNA MicC Contributes to Virulence in Outer Membrane Proteins in Salmonella Enteritidis
Published on: January 27, 2021
The mechanism of microcin C resistance provided by the MccF peptidase
Anton Tikhonov1, Teymur Kazakov, Ekaterina Semenova
1Institutes of Molecular Genetics and Gene Biology, Russian Academy of Sciences, Moscow, Russia.
Abstract:
The heptapeptide-nucleotide microcin C (McC) is a potent inhibitor of enteric bacteria growth. Inside a sensitive cell, McC is processed by aminopeptidases, which release a nonhydrolyzable aspartyl-adenylate, a strong inhibitor of aspartyl-tRNA synthetase. The mccABCDE operon is sufficient for McC production and resistance of the producing cell to McC. An additional gene, mccF, which is adjacent to but not part of the mccABCDE operon, also provides resistance to exogenous McC. MccF is similar to Escherichia coli LdcA, an L,D-carboxypeptidase whose substrate is monomeric murotetrapeptide L-Ala-D-Glu-meso-A(2)pm-D-Ala or its UDP-activated murein precursor. The mechanism by which MccF provides McC resistance remained unknown. Here, we show that MccF detoxifies both intact and processed McC by cleaving an amide bond between the C-terminal aspartate and the nucleotide moiety. MccF also cleaves the same bond in nonhydrolyzable aminoacyl sulfamoyl adenosines containing aspartyl, glutamyl, and, to a lesser extent, seryl aminoacyl moieties but is ineffective against other aminoacyl adenylates.
Insights
Microcin C (McC) inhibits bacteria, but MccF provides resistance by cleaving the bond between aspartate and the nucleotide. This enzyme detoxifies McC, protecting cells from its potent growth inhibition.
Area of Science:
- Microbiology
- Biochemistry
- Molecular Biology
Background:
- Microcin C (McC) is a heptapeptide-nucleotide antibiotic that inhibits enteric bacteria.
- McC is processed intracellularly to release aspartyl-adenylate, a potent inhibitor of aspartyl-tRNA synthetase.
- The mccABCDE operon confers McC production and resistance, while the adjacent mccF gene also provides resistance.
Purpose of the Study:
- To elucidate the mechanism by which the mccF gene product confers resistance to Microcin C.
- To investigate the enzymatic activity of MccF on Microcin C and related compounds.
Main Methods:
- Biochemical assays to determine the cleavage activity of MccF.
- Analysis of MccF's substrate specificity using various aminoacyl adenylates and sulfamoyl adenosines.
Main Results:
- MccF was shown to detoxify both intact and processed Microcin C.
- MccF cleaves the amide bond linking the C-terminal aspartate to the nucleotide moiety in McC.
- MccF also cleaves similar bonds in nonhydrolyzable aminoacyl sulfamoyl adenosines, with specificity for aspartyl and glutamyl moieties.
Conclusions:
- MccF confers resistance to Microcin C by enzymatically cleaving the critical aspartate-nucleotide bond.
- MccF exhibits carboxypeptidase-like activity, acting on the amide bond within McC and related structures.
- The findings reveal a novel detoxification mechanism against a potent bacterial toxin.
More Related Videos
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Gene Regulation in Microbial Communities: Quorum Sensing

